Edited By: Prof Yang Yang
Journal list menu
Clinical and Experimental Pharmacology and Physiology is a broad scope pharmacology journal aiming to advance the translation of basic research to clinical practice. The journal covers clinical and experimental pharmacology and physiology, blood pressure, cardiovascular disease, heart failure, pharmacokinetics, toxicology, and more.
Articles
Tanshinone IIA ameliorates the development of dermal fibrosis in systemic sclerosis
- Clinical and Experimental Pharmacology and Physiology
-  30 November 2023
Improved cardioprotective effect of 3-nitro-N-methyl salicylamide solution after a prolonged preservation time of rat heart
- Clinical and Experimental Pharmacology and Physiology
-  23 November 2023
Agomelatine alleviates steroid-induced osteoporosis by targeting SIRT1/RANKL/FOXO1/OPG signalling in rats
- Clinical and Experimental Pharmacology and Physiology
-  11 November 2023
IL-4/STAT6 axis observed to reverse proliferative defect in SCA3 patient-derived neural progenitor cells
- Clinical and Experimental Pharmacology and Physiology
-  7 November 2023
Pharmacogenomics and adverse effects of anti‐infective drugs in children
- Clinical and Experimental Pharmacology and Physiology
-  15 October 2023
Application of 3D computed tomography in emphysematous parenchyma patients scheduled for bronchoscopic lung volume reduction
- Clinical and Experimental Pharmacology and Physiology
-  8 October 2023
Growth hormone‐releasing hormone beyond cancer
- Clinical and Experimental Pharmacology and Physiology
-  26 September 2023
Pharmacodynamic study of chitosan in combination with salvianolic acid B in the treatment of CC14-induced liver fibrosis in mice
- Clinical and Experimental Pharmacology and Physiology
-  25 September 2023
Hsa_circ_0001204 modulates inflammatory response of macrophages infected by Mycobacterium tuberculosis via TLR4/NF-κB signalling pathway
- Clinical and Experimental Pharmacology and Physiology
-  132-139
-  23 November 2022
Research trends in ferroptosis since the origin of the concept: A bibliometric analysis
- Clinical and Experimental Pharmacology and Physiology
-  149-157
-  11 November 2022
Correction to “Ginsenoside 20(S)-Rg3 upregulates HIF-1α-targeting miR-519a-5p to inhibit the Warburg effect in ovarian cancer cells”
-  1005-1005
-  2 November 2023
Circ_0026579 knockdown ameliorates lipopolysaccharide-induced human lung fibroblast cell injury by regulating CXCR1 via miR-370-3p
-  992-1004
-  2 October 2023
Monocarboxylate transporter 4 protects against myocardial ischemia/reperfusion injury by inducing oxidative phosphorylation/glycolysis interconversion and inhibiting oxidative stress
-  954-963
-  28 September 2023
RAD140 (Testolone) negatively impacts skeletal muscle adaptation, frailty status and mortality risk in female mice
-  973-983
-  27 September 2023
Anti-prolactin treatment alleviates lupus conditions by regulating the JAK2–STAT3 pathway
-  936-943
-  20 September 2023
Impact of noscapine on halting the progression of pentylenetetrazole induced kindling epilepsy in mice
-  984-991
-  19 September 2023
Telocytes protect against lung tissue fibrosis through hexokinase 2‐dependent pathway by secreting hepatocyte growth factor
-  964-972
-  16 September 2023
Circ_0002295 facilitated myocardial fibrosis progression through the miR-1287/CXCR2 axis
-  944-953
-  9 September 2023
Rosiglitazone inhibits acyl‐CoA synthetase long‐chain family number 4 and improves secondary brain injury in a rat model of surgical brain injury
-  927-935
-  7 September 2023
Protective effect of melatonin and ascorbic acid combination on sepsis‐induced lung injury: An Experimental study
- Clinical and Experimental Pharmacology and Physiology
-  634-646
-  18 May 2023
Moxibustion ameliorates cerebral ischemia–reperfusion injury by regulating ferroptosis in rats
- Clinical and Experimental Pharmacology and Physiology
-  779-788
-  7 July 2023
Bufalin reduces myocardial infarction-induced myocardial fibrosis and improves cardiac function by inhibiting the NLRP3/IL-1β signalling pathway
- Clinical and Experimental Pharmacology and Physiology
-  688-697
-  27 May 2023
RAD140 (Testolone) negatively impacts skeletal muscle adaptation, frailty status and mortality risk in female mice
- Clinical and Experimental Pharmacology and Physiology
-  973-983
-  27 September 2023
A comprehensive review on medicinal plants possessing antioxidant potential
- Clinical and Experimental Pharmacology and Physiology
-  205-217
-  8 December 2022
Intraoperative hemodynamics and risk of cardiac surgery‐associated acute kidney injury: An observation study and a feasibility clinical trial
- Clinical and Experimental Pharmacology and Physiology
-  878-892
-  7 August 2023
Bach1 modulates AKT3 transcription to participate in hyperglycaemia-mediated EndMT in vascular endothelial cells
- Clinical and Experimental Pharmacology and Physiology
-  443-452
-  8 February 2023
Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy
- Clinical and Experimental Pharmacology and Physiology
-  749-756
-  29 June 2023
Omega‐3 polyunsaturated fatty acids in the treatment of non‐alcoholic fatty liver disease: An umbrella systematic review and meta‐analysis
- Clinical and Experimental Pharmacology and Physiology
-  327-334
-  24 January 2023
Role of the chloride channel blocker in the formation of filtering tract scars after glaucoma surgery in rats
- Clinical and Experimental Pharmacology and Physiology
-  806-814
-  15 July 2023